Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

564
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
564
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

693
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
693
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

309
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
309
Understanding Sleep01:11

Understanding Sleep

1.2K
Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

635
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
635

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Phenolic Nanocompounds in Inflammatory Disorders: Current View and Future Aspects.

Current pharmaceutical design·2026
Same author

Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology.

Bioscience reports·2026
Same author

Cognitive Decline in Atherosclerotic Diseases: Mechanisms and Potential Solutions.

CNS & neurological disorders drug targets·2026
Same author

Computational investigation of biochanin a targeting DEPTOR in Alzheimer's disease with in vitro cellular validation of neuroprotective activity.

Scientific reports·2026
Same author

Narrative Review "Dual Frontiers in Neurodegeneration: Pharmacological Synergies and Divergences in Parkinson's Disease and Type 2 Diabetes Mellitus".

Cellular and molecular neurobiology·2026
Same author

Advancements in nanobiosensors for early cancer detection, challenges, treatment, and future prospects: a comprehensive review.

Discover nano·2026

Related Experiment Video

Updated: Dec 10, 2025

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

5.8K

Decoding the Inter-Relationship between Sleep Disorders and Alzheimer's Disease Pathogenesis.

Zeba Mueed1, Pankaj Kumar Rai1, Mohammad Amjad Kamal2

  • 1Department of Biotechnology, Invertis University, Bareilly, Uttar Pradesh, India.

CNS & Neurological Disorders Drug Targets
|September 5, 2020
PubMed
Summary

Sleep disturbances are linked to Alzheimer's Disease (AD) pathology, creating a bidirectional relationship. Melatonin shows neuroprotective effects, and therapies targeting sleep may help manage AD progression.

Keywords:
Alzheimer's Disease (AD)amyloidastrocytes.circadian rhythmmelatoninsleep disturbancestau

More Related Videos

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.1K
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.9K

Related Experiment Videos

Last Updated: Dec 10, 2025

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

5.8K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.1K
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.9K

Area of Science:

  • Neuroscience
  • Pathology
  • Sleep Medicine

Background:

  • Alzheimer's Disease (AD) involves tau pathology, amyloid-beta (Aβ) deposits, and deregulated mTOR.
  • Sleep disorders are increasingly recognized as a contributing factor to AD pathogenesis.
  • A complex, bidirectional relationship exists between sleep disturbances and AD pathology.

Purpose of the Study:

  • To review and elucidate the reciprocal relationship between sleep disturbances and Alzheimer's Disease.
  • To explore the roles of tau and amyloid pathology in sleep disruption and AD.
  • To discuss the neuroprotective potential of melatonin and other therapeutic strategies.

Main Methods:

  • Literature review focusing on the interplay between sleep, tau, and amyloid pathology.
  • Analysis of studies investigating melatonin's role in sleep regulation and AD.
  • Examination of therapeutic interventions for co-occurring sleep disorders and AD.

Main Results:

  • Evidence suggests a positive feedback loop between sleep pathology and AD.
  • Melatonin demonstrates neuroprotective effects by inhibiting tau hyperphosphorylation and Aβ deposition.
  • Astrocytes play a role in exacerbating AD pathology.

Conclusions:

  • The etiology of sleep disorders and AD is multifactorial and not fully understood.
  • Further research is crucial to unravel underlying mechanisms and develop preclinical AD interventions.
  • Therapeutic strategies targeting sleep improvement may offer a novel approach to managing AD.